Want to join the conversation?
CEO Sean Healey said $AMG is positioned to generate further earnings growth ahead, given its continuing asset growth, the quality of its Affiliates and their long-term performance track records, and the ongoing success of its strategy to partner with the highest-quality boutiques worldwide.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.